Is metformin safe?
Metformin has one of the longest safety records of any prescription medication — used for type 2 diabetes since the 1990s and studied in millions of people. For longevity it’s prescribed off-label, at doses similar to its diabetes use, under lab monitoring. It also carries real, known side effects, and it isn’t right for everyone. Here’s an honest look at both, so you can decide with a clinician whether it fits your situation.
How it works — and where risk comes from
What metformin does, and what that means for safety
The side effects, stated plainly
No effective medication is risk-free, and metformin is no exception. Its record is long and well-characterized, which means its risks are known rather than hidden:
- Gastrointestinal effects (nausea, diarrhea, cramping) — the most common, usually dose-related and often eased by extended-release dosing and taking it with food
- Reduced vitamin B12 absorption over long-term use — monitored in labs and corrected with supplementation if needed
- A very rare risk of lactic acidosis, almost always tied to significant kidney impairment or acute illness
- Not appropriate with significant kidney or liver disease, unstable heart failure, or around iodinated-contrast imaging
Extended-release dosing, gradual titration and lab monitoring are intended to reduce these risks, but they do not eliminate them — and some people are advised not to take metformin at all. That is why the protocol pairs any prescription with kidney-function and B12 monitoring and clinician oversight. Your clinician determines whether it is appropriate for you.
What the research actually shows
Read the evidence for yourself, including its limits. Human longevity data is still emerging; the TAME trial is the study designed to test metformin for aging directly.
The TAME trial: how a diabetes drug could change the way we age
Rapamycin, acarbose and metformin: what a combined longevity protocol suggests
Aging is not uniform: mapping biological age at the level of cell types
The autonomic imbalance theory of aging: an upstream driver of the hallmarks
Metformin safety: common questions
Metformin has one of the longest safety records of any prescription medication — it has been used for type 2 diabetes since the 1990s and studied in millions of people. For longevity it is used off-label, and human longevity evidence is still emerging (the TAME trial is designed to test it directly). "Safe" is never absolute: metformin has known side effects and is not appropriate for everyone, particularly people with significant kidney disease. Whether it fits you depends on your health history and lab work, which a licensed clinician reviews before prescribing.
The most common side effects are gastrointestinal — nausea, diarrhea, and stomach cramping — especially when starting. These are usually dose-related and often ease with extended-release metformin, gradual titration, and taking it with food. Long-term use can lower vitamin B12 levels, which is why B12 is monitored and supplemented if needed. A very rare but serious risk is lactic acidosis, almost always tied to impaired kidney function or acute illness — which is exactly what the kidney screening and lab monitoring are designed to prevent.
Metformin is generally not appropriate for people with significant kidney impairment (it is cleared by the kidneys), unstable heart failure or liver disease, or during acute illness, dehydration, or around imaging that uses iodinated contrast. Excessive alcohol use also raises the risk of lactic acidosis. This is what the clinical intake, kidney-function (eGFR) check and lab review are for — the clinician, not the patient, decides whether it is appropriate.
Long-term metformin use can reduce vitamin B12 absorption, and over years this can lower B12 levels in some people. It is a well-recognized effect, not a hidden one: B12 is included in follow-up lab monitoring, and if levels drop, supplementation corrects it. This is one of the specific reasons ongoing lab work is part of the protocol rather than a one-time prescription.
A Healthspan protocol includes baseline and follow-up lab testing — kidney function (eGFR), metabolic markers and vitamin B12 — plus ongoing clinician oversight and dosing that can be adjusted or paused. Extended-release metformin and gradual titration reduce the most common (GI) side effects. Medication is dispensed through a certified pharmacy. Monitoring is how individual risk is managed over time.
No. Metformin is FDA-approved to treat type 2 diabetes, not longevity or anti-aging. Using it for longevity is off-label, meaning a licensed clinician prescribes an approved drug for a use outside its labeling based on clinical judgment. There are no proven human anti-aging or lifespan claims for metformin; the TAME trial is the study designed to test whether targeting aging with metformin works, and its results are still awaited.
Metformin has one of the longest safety records of any prescription medication — it has been used for type 2 diabetes since the 1990s and studied in millions of people. For longevity it is used off-label, and human longevity evidence is still emerging (the TAME trial is designed to test it directly). "Safe" is never absolute: metformin has known side effects and is not appropriate for everyone, particularly people with significant kidney disease. Whether it fits you depends on your health history and lab work, which a licensed clinician reviews before prescribing.
The most common side effects are gastrointestinal — nausea, diarrhea, and stomach cramping — especially when starting. These are usually dose-related and often ease with extended-release metformin, gradual titration, and taking it with food. Long-term use can lower vitamin B12 levels, which is why B12 is monitored and supplemented if needed. A very rare but serious risk is lactic acidosis, almost always tied to impaired kidney function or acute illness — which is exactly what the kidney screening and lab monitoring are designed to prevent.
Metformin is generally not appropriate for people with significant kidney impairment (it is cleared by the kidneys), unstable heart failure or liver disease, or during acute illness, dehydration, or around imaging that uses iodinated contrast. Excessive alcohol use also raises the risk of lactic acidosis. This is what the clinical intake, kidney-function (eGFR) check and lab review are for — the clinician, not the patient, decides whether it is appropriate.
Long-term metformin use can reduce vitamin B12 absorption, and over years this can lower B12 levels in some people. It is a well-recognized effect, not a hidden one: B12 is included in follow-up lab monitoring, and if levels drop, supplementation corrects it. This is one of the specific reasons ongoing lab work is part of the protocol rather than a one-time prescription.
A Healthspan protocol includes baseline and follow-up lab testing — kidney function (eGFR), metabolic markers and vitamin B12 — plus ongoing clinician oversight and dosing that can be adjusted or paused. Extended-release metformin and gradual titration reduce the most common (GI) side effects. Medication is dispensed through a certified pharmacy. Monitoring is how individual risk is managed over time.
No. Metformin is FDA-approved to treat type 2 diabetes, not longevity or anti-aging. Using it for longevity is off-label, meaning a licensed clinician prescribes an approved drug for a use outside its labeling based on clinical judgment. There are no proven human anti-aging or lifespan claims for metformin; the TAME trial is the study designed to test whether targeting aging with metformin works, and its results are still awaited.
Metformin is a prescription medication, FDA-approved for type 2 diabetes. For longevity it is prescribed off-label, and human longevity evidence is still emerging. Metformin has known side effects — most commonly gastrointestinal, plus reduced vitamin B12 over time and a rare risk of lactic acidosis — and is not appropriate for everyone, particularly people with significant kidney disease. A licensed clinician determines whether it is appropriate for you. This page is educational and not medical advice; individual results vary.